ProHealth health Vitamin and Natural Supplement Store and Health
Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help

|
|
|
|

Trending News

CDC Whistleblower Reveals Widespread Manipulation of Scientific Data and Top-Down Pressure on CDC Sc...

How Glutathione Can Save Your Life

Reversing Neurodegeneration with a New Magnesium Compound

Coenzyme Q10 Benefits Symptoms in Gulf War Veterans: Results of a Randomized Double-Blind Study

Gut Bacteria, Artificial Sweeteners and Glucose Intolerance

Brain inflammation dramatically disrupts memory retrieval networks, UCI study finds

Scientists discover how to 'switch off' autoimmune diseases

Clinical trial demonstrates safety, effectiveness of immunotherapy for AdV, BKV, and herpesviruses i...

Surprising discovery: HIV hides in gut, evading eradication

New estrogen-based compound suppresses binge-like eating behavior in female mice

 
Print Page
Email Article

Recalibrating 'fight or flight' – counter-intuitive new treatment for chronic fatigue syndrome (ME/CFS) & other chronic stress disorders

  [ 18 votes ]   [ 3 Comments ]
By Public Library of Science • www.ProHealth.com • January 23, 2009


“Akin to pulling back a slingshot, temporarily reducing the bioavailability of cortisol pharmacologically causes the HPA axis to overcompensate and launch itself back into a correct regulatory regime.”

A Canadian/U.S. research team has reported a novel approach to stimulating recovery from chronic stress disorders.

Details of the therapeutic model, which exploits the natural dynamics of the body's "fight or flight" system, [can be found online] in the open-access journal PLoS Computational Biology.(1) In contrast to conventional time-invariant therapy, the researchers propose a well-directed therapeutic push delivered according to an optimal treatment schedule.

The hypothalamic, pituitary, adrenal (HPA) axis constitutes one of the body's major control systems, serving to maintain body homeostasis with hormone feedback regulatory loops.

If the HPA axis is driven very far from its natural homeostatic rest point, it may be unable to fully recover the healthy physiologic state. Under such conditions, the HPA axis dysfunction may become chronic.

HPA axis dysfunction has been characterized in disorders including chronic fatigue syndrome [ME/CFS], depression, post-traumatic stress disorder, and Alzheimer’s disease.

The research team, consisting of Drs. Amos Ben-Zvi, Suzanne D. Vernon [scientific director of the CFIDS Association of America], and Gordon Broderick, used a relatively simple mathematical description of the HPA axis to show how the complex dynamical behavior of this system could accommodate multiple stable resting states; some corresponding to chronic loss of function characterized by low cortisol, a hormone that modulates immune function.

A robust treatment strategy was designed to take advantage of the body's existing homeostatic mechanism, using a short-duration intervention to assist the HPA axis in re-asserting homeostasis about a healthy equilibrium.

Akin to pulling back a slingshot, temporarily reducing the bioavailability of cortisol pharmacologically causes the HPA axis to overcompensate and launch itself back into a correct regulatory regime.

The Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia estimates that between 1 and 4 million Americans suffer from CFS, and only half have consulted a physician for their illness. The CDC and DePaul University have estimated CFS costs the US economy approximately $30 billion each year in health care and lost productivity.

The researchers propose a theoretical, single intervention therapeutic model that is counter-intuitive and challenges the conventional time-invariant approach to many therapies. Validation of this model will require clinical collaboration.
____
1. Link to full text article: “Model-Based Therapeutic Correction of Hypothalamic-Pituitary-Adrenal Axis Dysfunction,” Ben-Zvi A, Vernon SD, Broderick G. PLoS Computational Biology, Jan 23, 2009

See also:

• Previous article on this work: “Neuroendocrine and Immune Network Re-modeling in Chronic Fatigue Syndrome: An Exploratory Analysis,” Genomics, Sep 4, 2008.

• ProHealth's “Q&A Session with ME/CFS Research Expert Suzanne Vernon, PhD – Dec 5, 2008” - addressing this and other current research funded by the CFIDS Association.

PLoS Disclaimer: This press release refers to an article in PLoS Computational Biology. The release is provided by the article authors. Any opinions expressed in this release or article are the personal views of the journal staff and/or article contributors, and do not necessarily represent the views or policies of PLoS. PLoS expressly disclaims any and all warranties and liability in connection with the information found in the releases and articles and your use of such information.



Please Discuss This Article:   Post a Comment 

How will this work if you have normal cortisol levels?
Posted by: outofstep
Jan 25, 2009
If you have neuroinflammation and neurotoxic damage and it is causing HPA axis dysfunction then won't it continue until the underlying cause is treated? It looks like this study only addresses one subgroup of CFS patients-the ones who are being studied by the CDC who have something related to post-traumatic stress disorder.
Reply Reply

cortisol suppression
Posted by: groupie
Jan 28, 2009
As someone who takes Cortef 20 mg daily for ME/CFS related adrenal insufficiency, I am bowled over by this opposite strategy proposal. Perhaps collapse into extreme weakness following a crisis is the body's intelligence at work?
Reply Reply

More Bandaid Medicine
Posted by: shartau
Feb 15, 2009
I really wish that these physicians would work on CAUSE and CURE instead of more Bandaids. Sick to death of theroeticals. Get on with it.
Reply Reply


Post a Comment

 
Free Chronic Fatigue Syndrome and Fibromyalgia Newsletters
Subscribe to
Our FREE
Newsletter
Subscribe Now!
Receive up-to-date ME/CFS & Fibromyalgia treatment and research news
 Privacy Guaranteed  |  View Archives

Save on Vitamins and Supplements

Featured Products

Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
FibroSleep™ by ProHealth FibroSleep™ by ProHealth
The All-in-One Natural Sleep Aid
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium

Natural Remedies

How I Found My Long-Lost Energy How I Found My Long-Lost Energy
Anti-Inflammatory Properties of Tart Cherry Anti-Inflammatory Properties of Tart Cherry
Research Links Green Tea to Weight Loss Research Links Green Tea to Weight Loss
The Curcumin Revolution: The Curcumin Revolution: "Golden" Ticket to Better Health
Preserving Cognitive Function with Aging Preserving Cognitive Function with Aging

FIBROMYALGIA RESOURCES
What is Fibromyalgia?
Fibromyalgia 101
Fibromyalgia Symptoms
Fibromyalgia Treatments
| CFS RESOURCES
What is CFS?
ME/CFS 101
ME/CFS Symptoms
ME/CFS Treatments
| FORUMS
Fibromyalgia
ME/CFS
ADVANCED MEDICAL LABS
WHOLESALE  |  AFFILIATES
GUARANTEE
CONTACT US
PRIVACY
RSS
SITE MAP
ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus
Credit Card Processing